asxan.ai Agents Hub

Reproductive Wellness

Evidence Stack

Male & female fertility context · sperm parameters · micronutrient adequacy

Evidence-first reproductive wellness stack — what the human-evidence record actually shows for the micronutrients and cofactors most associated with sperm parameters and fertility-context adequacy, including the honest live-birth nulls. This is mechanism and evidence mapping, not medical advice. Diagnosed reproductive disorders require physician-led management; discuss any reproductive supplementation with a reproductive endocrinologist or appropriately credentialed clinician. All PubMed identifiers are verified against PubMed before inclusion; cross-market regulatory claims appear verbatim per their authorising authority (FDA · EFSA · ANVISA · TGA).

Last reviewed · How we assess evidence →

Quick Summary

  • Salas-Huetos 2018 nutrient sperm meta-analysis is the field-level overview. Salas-Huetos 2018 (PMID 30462179) Advances in Nutrition systematic review and meta-analysis of 28 articles examined the effect of nutrients and dietary supplements on sperm quality parameters in randomized clinical trials. This is the modern overarching field anchor — read it before reading any single-ingredient claim. See CoQ10, L-Carnitine, and Zinc.
  • CoQ10 improves sperm lab parameters but NOT live birth / pregnancy rates. Lafuente 2013 (PMID 23912751) Journal of Assisted Reproduction and Genetics meta-analysis reported CoQ10 supplementation improved seminal CoQ10 concentration, sperm count, and motility — but explicitly stated there is NO evidence CoQ10 increases live birth or pregnancy rates. The honest framing: lab parameter signal, NOT clinical outcome.
  • L-Carnitine 2 g/day improved sperm concentration and motility in a single double-blind crossover RCT. Lenzi 2003 (PMID 12568837) Fertility and Sterility at 2 g/day showed statistically significant improvements in sperm concentration and total / forward motility vs placebo in selected male-factor infertility cases. Single-trial, modest-n — preliminary / emerging, replication-pending.
  • Zinc supplementation supports semen volume, motility, and normal morphology — but is NOT a fertility cure. Zhao 2016 (PMID 26932683) Scientific Reports systematic review + meta-analysis supports zinc supplementation effect on sperm parameters. Irani 2017 (PMID 28853101) Urology Journal extends with combined folate + zinc in subfertile men. These are sperm-parameter signals, NOT live-birth endpoints.
  • de Ligny 2022 Cochrane: antioxidants for male subfertility = very-low-certainty evidence on live birth. de Ligny 2022 (PMID 35506389) Cochrane Database of Systematic Reviews analyzed 90 RCTs with 10,303 subfertile men and concluded the evidence on antioxidant supplementation improving live-birth rate is very-low certainty — i.e. the field-level evidence remains inconclusive due to methodological limitations. The honest framing for any single-ingredient sperm-parameter claim must acknowledge this Cochrane caveat.
  • This is not medical advice. Diagnosed reproductive disorders require physician-led management. The stack below is mechanism and evidence mapping — discuss any reproductive supplementation with a reproductive endocrinologist or appropriately credentialed clinician.

The Evidence Stack

The "evidence" column below describes the strength and direction of the outcome evidence in qualitative terms — well-established, robust, moderate/mixed, preliminary/emerging, or null/negative. The S/A/B/C tier that grades how extensively an ingredient is studied (its evidence volume) lives on each linked ingredient page, not here.

Ingredient / Anchor Reproductive evidence (qualitative) Key Trial / Meta-analysis asxan.ai page
Salas-Huetos 2018 (field overview) Robust field-level overview — modern SR + MA across 28 RCTs of nutrients / supplements on sperm quality parameters Salas-Huetos 2018 PMID 30462179 (Adv Nutr · nutrient / supplement sperm quality parameters · 28 articles qualitative · 15 quantitative meta-analysis) Field-level reading · not an ingredient page
CoQ10 Moderate / mixed — sperm lab parameters improved (count, motility, seminal CoQ10); live-birth / pregnancy endpoint null (Lafuente 2013) Lafuente 2013 PMID 23912751 (J Assist Reprod Genet · CoQ10 sperm count + motility + seminal CoQ10 ↑; NO live birth / pregnancy rate increase) /ingredients/coq10/
L-Carnitine Preliminary / emerging — single double-blind crossover RCT, modest n; sperm-parameter signal, replication-pending Lenzi 2003 PMID 12568837 (Fertil Steril · 2 g/day double-blind crossover · sperm concentration + total / forward motility improvement) /ingredients/l-carnitine/
Zinc Moderate / mixed — sperm-parameter meta supports semen volume, motility, morphology; NOT a live-birth endpoint claim Zhao 2016 PMID 26932683 (Sci Rep · zinc seminal plasma SR + MA · semen volume + motility + morphology); Irani 2017 PMID 28853101 (Urol J · folate + zinc combined in subfertile men) /ingredients/zinc/
Folate (fertility-context) Preliminary / emerging — dietary folate modifies the BPA-IVF outcome association in women; fertility-context, not NTD-context Mínguez-Alarcón 2016 PMID 27423903 (Reprod Toxicol · dietary folate modifies BPA-IVF outcome association · Gaskins co-author); Irani 2017 PMID 28853101 (folate + zinc combined) /ingredients/folate/ (NTD anchor is on the pregnancy page)
Cochrane Antioxidants Overview (de Ligny 2022) Null / negative on live birth — antioxidant supplementation improving live-birth rate is very-low certainty across 90 RCTs de Ligny 2022 PMID 35506389 (Cochrane Database · 90 RCTs · 10,303 subfertile men · live-birth evidence very-low certainty) Field-level reading · not an ingredient page
Astaxanthin (cross-system reference) Preliminary / emerging for reproductive endpoint (not in hand); cross-system signals robust on skin / fatigue / motor Zhou 2021 PMID 34578794 (skin meta); Liu 2024 PMID 38243785 (fatigue / motor meta) — reproductive-specific endpoint NOT in hand /ingredients/astaxanthin/ (not on a reproductive endpoint)
Maca (NOT recommended) Null / negative — Shin 2010 SR concludes "limited evidence" for sexual-function effectiveness; excluded from stack Shin 2010 PMID 20691074 (BMC Complement Altern Med · maca SR · "limited evidence for effectiveness" in sexual function) — see the Nulls section Reference only · not on the asxan.ai stack

How It Works

Each ingredient engages reproductive biology by a different route — CoQ10 through mitochondrial electron transport, L-carnitine through long-chain fatty-acid mitochondrial import, zinc through seminal-plasma adequacy and oxidative-stress modulation, and folate through one-carbon metabolism in the fertility context.

Sperm bioenergetics — CoQ10 mitochondrial electron transport. Mature spermatozoa are highly dependent on mitochondrial ATP for motility. CoQ10 (ubiquinone / ubiquinol) is a mobile electron carrier in the mitochondrial respiratory chain. Oral CoQ10 supplementation raises seminal plasma CoQ10 concentration and is associated with sperm parameter improvements in meta-analysis (Lafuente 2013 PMID 23912751). The clinically important honest caveat: lab parameter improvements have NOT translated into reproducible live-birth rate increases in this meta-analysis.

L-Carnitine and long-chain fatty acid transport into mitochondria. L-Carnitine shuttles long-chain fatty acids across the inner mitochondrial membrane for β-oxidation; sperm energetics are partially carnitine-dependent. Lenzi 2003 (PMID 12568837) double-blind crossover RCT at 2 g/day reported sperm concentration and total / forward motility improvements vs placebo. The anchor is single-trial, modest-n — preliminary / emerging, replication-pending.

Zinc and seminal plasma adequacy. Zinc is concentrated in seminal plasma at far higher concentrations than serum; it has established roles in spermatogenesis, sperm capacitation, and oxidative-stress modulation. Zhao 2016 (PMID 26932683) meta-analysis supports zinc supplementation effects on semen volume, motility, and normal morphology. Irani 2017 (PMID 28853101) extended the signal with combined folate + zinc in subfertile men. The endpoint is sperm parameter — NOT live birth.

Folate and one-carbon metabolism in fertility context. Folate participates in one-carbon metabolism (purine / pyrimidine / methionine synthesis); adequate folate status supports gametogenesis and early embryonic development. Mínguez-Alarcón 2016 (PMID 27423903) demonstrated that dietary folate intake modifies the urinary BPA — IVF implantation association in women undergoing assisted reproduction. This is the reproductive-context folate signal — the established NTD-prevention folate anchor (MRC 1991 PMID 1672732, Czeizel 1992 PMID 1307234) is on the pregnancy page, not here.

de Ligny 2022 Cochrane is the methodological reality check. de Ligny 2022 (PMID 35506389) Cochrane Database meta-analysis of 90 RCTs with 10,303 subfertile men concluded that the evidence on antioxidant supplementation improving live-birth rates is very-low certainty due to methodological limitations. Single-ingredient sperm-parameter signals do exist (CoQ10 / Zinc / L-Carnitine meta + RCT) but the live-birth field-level outcome is not robustly established. Any reproductive-supplementation discussion must acknowledge this Cochrane caveat.

Astaxanthin reproductive mechanism is not a reproductive-endpoint claim on this page. Astaxanthin lipophilic ROS scavenging is mechanism-plausible for sperm membrane oxidative-stress reduction; however, reproductive-specific RCT evidence is NOT in hand. Astaxanthin's cross-system signals live in skin (Zhou 2021 PMID 34578794) and fatigue / motor (Liu 2024 PMID 38243785) — see Senior 60+.

Body systems engaged: Reproductive. Mechanism tags: Hormone regulation · Free radical scavenging · Coenzyme metabolism.

What the Trials Show — Including the Nulls

This page does NOT support claims of curing, treating, or reversing infertility, polycystic ovary syndrome, endometriosis, or any other diagnosed reproductive disorder. Couples experiencing infertility (typically defined as 12 months of attempted conception without success in women under 35) should consult a reproductive endocrinologist or appropriately credentialed clinician for diagnostic workup. The asxan.ai reproductive-wellness stack is a complement to — not a substitute for — clinical fertility care.

L-Carnitine signal is single-RCT, modest-n. Lenzi 2003 (PMID 12568837) at 2 g/day double-blind crossover reported sperm-parameter improvements but the anchor is one DBPC trial — not a robust meta-analytic anchor. Larger replication trials would strengthen the signal; the honest framing is "preliminary / emerging, replication-pending," not "well-established."

Zinc signals are on sperm parameters, NOT live birth. Zhao 2016 (PMID 26932683) and Irani 2017 (PMID 28853101) meta-analyses support sperm parameter improvements but did NOT establish zinc as a live-birth intervention. Combined folate + zinc supplementation in subfertile men remains a sperm-parameter, not couple-outcome, claim.

Maca evidence for sexual function is limited. Shin 2010 (PMID 20691074) BMC Complement Altern Med systematic review concluded "limited evidence for the effectiveness of maca in improving sexual function." Maca is NOT on the asxan.ai stack for reproductive wellness — it is reference-only, with explicit limited-evidence framing.

Astaxanthin is not on reproductive endpoints. Astaxanthin's meta-analytic signals are on skin (Zhou 2021 PMID 34578794) and cross-system fatigue / motor (Liu 2024 PMID 38243785). Reproductive-specific RCT evidence is NOT in hand — astaxanthin appears on this page as cross-system reference context, NOT as a reproductive-endpoint claim.

Stacking & Timeline

Mechanistic pairings are plausible but rarely backed by head-to-head synergy trials; realistic timelines run from one spermatogenic cycle (~3 months for sperm-parameter change) to a year or more (couple-level conception / live-birth endpoints, which remain very-low certainty).

Mechanistic pairs

CoQ10 + L-Carnitine · the mitochondrial bioenergetics pair. CoQ10 (Lafuente 2013 PMID 23912751) and L-Carnitine (Lenzi 2003 PMID 12568837) act on different mitochondrial mechanisms (CoQ10 electron transport vs L-Carnitine fatty-acid transport) — the combination is mechanism-plausible. Direct head-to-head pair-RCT data are limited; both ingredients are sperm-parameter (NOT live-birth) anchored.

Zinc + Folate (subfertile men) · the combined micronutrient pair. Irani 2017 (PMID 28853101) Urology Journal meta-analysis examined combined folate + zinc supplementation specifically in subfertile men, anchoring the pair within the broader micronutrient framework. The endpoint is sperm parameter, not live birth.

Salas-Huetos 2018 + de Ligny 2022 · the field-level reading pair. Salas-Huetos 2018 (PMID 30462179) and de Ligny 2022 (PMID 35506389) together provide the modern field overview: positive single-ingredient sperm-parameter signals (Salas-Huetos) with very-low-certainty live-birth evidence (de Ligny). Read both before assigning weight to any single-ingredient claim.

Dietary adequacy + lifestyle · the structural foundation. Mediterranean-pattern dietary intake, adequate sleep, physical activity, smoking cessation, and weight management remain the most important non-supplemental fertility-context interventions. Supplementation is layered on top of dietary and lifestyle adequacy — NOT a replacement for them.

When to see results — realistic timeframes

~3 months · spermatogenesis cycle. Spermatogenesis takes approximately 74 days in humans, plus epididymal maturation. Sperm-parameter intervention signals typically require at least 3 months (one spermatogenic cycle) of sustained supplementation before measurable change is expected. Sub-3-month durations are mechanistically too short.

3–6 months · CoQ10 / L-Carnitine / Zinc sperm-parameter signals. Lafuente 2013 (PMID 23912751) meta-analytic trials, Lenzi 2003 (PMID 12568837) DBPC crossover, and Zhao 2016 (PMID 26932683) zinc meta-analytic trials predominantly used 3–6 month intervention windows for sperm-parameter outcomes.

12+ months · couple-level conception / live-birth endpoints. Couple-level conception and live-birth outcomes require longer follow-up windows and are NOT detectable on a 3–6 month sperm-parameter horizon. de Ligny 2022 (PMID 35506389) Cochrane very-low-certainty caveat applies to this longer endpoint.

Lifetime · dietary adequacy and lifestyle as the cumulative substrate. Reproductive health is downstream of long-term dietary, lifestyle, environmental, and clinical factors. Supplementation is layered on top of these — NOT a replacement.

  • /lifestyles/high-stress/
  • /lifestyles/senior-60-plus/
  • Pregnancy — the NTD-prevention folate anchor (MRC 1991 PMID 1672732, Czeizel 1992 PMID 1307234) is on the pregnancy life-stage page, NOT here.
  • Heart Health — CoQ10 has cardiovascular evidence-base cross-link; ubiquinol is used in some HF / statin-myalgia contexts.
  • High Stress — chronic stress and HPA-axis activation impact reproductive endocrinology; cortisol regulation context relevant.
  • Senior 60+ — astaxanthin cross-system fatigue / motor signal (Liu 2024 PMID 38243785) is anchored here, not on a reproductive endpoint.

Frequently Asked Questions

1. Does CoQ10 actually make my partner more fertile?

The honest answer per the published meta-analysis: CoQ10 improves sperm lab parameters (concentration, motility, seminal CoQ10) but Lafuente 2013 (PMID 23912751) explicitly stated there is NO evidence that CoQ10 increases live birth or pregnancy rates. Lab parameter improvement does NOT translate reliably into pregnancy outcome. CoQ10 should be characterized as a sperm-parameter intervention with unproven clinical-endpoint translation, NOT a fertility-rate intervention.

2. Should L-Carnitine be on the stack?

L-Carnitine has a single foundational DBPC crossover RCT (Lenzi 2003 PMID 12568837) at 2 g/day showing sperm concentration and motility improvements in selected male-factor infertility — but the anchor is single-trial, modest-n. The signal is preliminary / emerging, replication-pending. It is included on this stack with that honest caveat.

3. Does zinc make sperm better?

Zhao 2016 (PMID 26932683) Scientific Reports meta-analysis supports zinc supplementation effects on semen volume, motility, and normal morphology. Irani 2017 (PMID 28853101) Urology Journal extended with combined folate + zinc in subfertile men. The endpoint is sperm parameter — NOT live birth. Zinc is generally well-tolerated at moderate doses; excessive long-term high-dose zinc can impair copper absorption.

4. What does the Cochrane review say about antioxidants for male subfertility?

de Ligny 2022 (PMID 35506389) Cochrane Database of Systematic Reviews analyzed 90 RCTs with 10,303 subfertile men and concluded the evidence on antioxidant supplementation improving live-birth rates is very-low certainty. This means: single-ingredient sperm-parameter improvements do exist (CoQ10 / Zinc / L-Carnitine signals are real on lab parameters) but the couple-level live-birth outcome is NOT robustly established. The Cochrane caveat is the methodological reality check for the entire field.

5. Does maca improve fertility or sexual function?

Shin 2010 (PMID 20691074) BMC Complementary and Alternative Medicine systematic review searched 17 databases and concluded "limited evidence for the effectiveness of maca in improving sexual function." Maca is NOT on the asxan.ai reproductive-wellness stack — it is reference-only, with the explicit limited-evidence framing.

6. Should we just go to a fertility clinic?

Yes, if you meet clinical criteria. Infertility is typically defined as 12 months of attempted conception without success in women under 35, or 6 months in women 35 and older. Earlier evaluation is appropriate when there are known risk factors (irregular cycles, prior fertility issues, known male-factor history, etc.). A reproductive endocrinologist or appropriately credentialed clinician should perform the diagnostic workup. Supplementation is a complement to — NOT a substitute for — clinical fertility care.

7. Why is folate listed in a fertility context and not as a neural-tube-defect anchor?

The asxan.ai fertility-context folate anchor is Mínguez-Alarcón 2016 (PMID 27423903), which demonstrates that dietary folate intake modifies the urinary BPA — IVF implantation association in women undergoing assisted reproduction. That is a reproductive-context, dietary-adequacy signal. The established NTD-prevention folate anchor (MRC 1991 PMID 1672732, Czeizel 1992 PMID 1307234) lives on the pregnancy life-stage page, not here. The two folate contexts are kept separate on purpose.

References

All PMIDs verified against PubMed. Effect sizes are reported as published.

Citation corrections. Several anchors were corrected to their verified PubMed records, including de Ligny 2022 (PMID 35506389, year corrected from an earlier 2019) and Shin 2010 (PMID 20691074, attribution corrected from Lee). Lafuente 2013 (PMID 23912751), Zhao 2016 (PMID 26932683), and Mínguez-Alarcón 2016 (PMID 27423903) are the verified anchors.

  1. PMID 30462179 · Salas-Huetos 2018 · Adv Nutr · nutrient / dietary-supplement effect on sperm quality parameters · SR + MA · 28 articles (15 quantitative) — field-level overview
  2. PMID 23912751 · Lafuente 2013 · J Assist Reprod Genet · CoQ10 sperm meta-analysis · sperm count + motility + seminal CoQ10 ↑; NO live birth / pregnancy rate increase
  3. PMID 12568837 · Lenzi 2003 · Fertil Steril · L-carnitine 2 g/day double-blind crossover RCT · sperm concentration + total / forward motility improvement (single-trial, modest-n)
  4. PMID 26932683 · Zhao 2016 · Sci Rep · zinc seminal-plasma SR + MA · semen volume + motility + normal morphology (sperm-parameter, not live-birth)
  5. PMID 28853101 · Irani 2017 · Urol J · combined folate + zinc supplementation in subfertile men (sperm-parameter endpoint)
  6. PMID 35506389 · de Ligny 2022 · Cochrane Database Syst Rev · antioxidants for male subfertility · 90 RCTs · 10,303 men · live-birth evidence very-low certainty
  7. PMID 27423903 · Mínguez-Alarcón 2016 · Reprod Toxicol · dietary folate modifies the BPA-IVF outcome association in women undergoing assisted reproduction (Gaskins co-author)
  8. PMID 20691074 · Shin 2010 · BMC Complement Altern Med · maca systematic review · "limited evidence for effectiveness" in sexual function (reference-only; off the stack)
  9. PMID 34578794 · Zhou 2021 · astaxanthin skin meta-analysis (cross-system reference; not a reproductive endpoint)
  10. PMID 38243785 · Liu 2024 · astaxanthin fatigue / motor meta-analysis (cross-system reference; not a reproductive endpoint)
  11. PMID 1672732 · MRC 1991 · folate NTD-prevention trial (cross-reference · anchored on the pregnancy page, not here)
  12. PMID 1307234 · Czeizel 1992 · periconceptional folate NTD-prevention trial (cross-reference · anchored on the pregnancy page, not here)

Coverage Notes

This Reproductive Wellness page draws from five linked ingredient pages on asxan.ai: astaxanthin (whose signals are cross-system — skin / fatigue / motor — and do NOT extend to a reproductive endpoint), CoQ10, L-Carnitine, Zinc, and Folate. This page describes their reproductive evidence qualitatively (well-established / robust / moderate–mixed / preliminary–emerging / null–negative) in the evidence stack and treats them as mechanism candidates in How It Works. The overarching de Ligny 2022 Cochrane caveat (very-low-certainty on live birth) is foregrounded across the Quick Summary, How It Works, and the Nulls section. Maca (Shin 2010 PMID 20691074) is reference-only and explicitly off the stack on a limited-evidence basis. Citations on this page are verified against PubMed (first author, year, title, and journal checked against the PubMed record), including the Lafuente 2013 (23912751), Zhao 2016 (26932683), de Ligny 2022 (35506389), Shin 2010 (20691074), Mínguez-Alarcón 2016 (27423903), and Lenzi 2003 (12568837) anchors.

← Home

Ask Agent Axor